机构:
UCL, Univ Coll Med Sch, Div Infect & Immun Royal Free, London W1T 4JF, EnglandUCL, Univ Coll Med Sch, Div Infect & Immun Royal Free, London W1T 4JF, England
Towers, Greg J.
[1
]
机构:
[1] UCL, Univ Coll Med Sch, Div Infect & Immun Royal Free, London W1T 4JF, England
Lv1;
Ref1;
restriction;
retrovirus;
species specificity;
TRIN45;
alpha;
tripartite;
zoonosis;
D O I:
10.2217/17460794.1.1.71
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Despite multiple transfers of primate lentiviruses to humans, the current AIDS pandemic has resulted from a single zoonosis of simian immunodeficiency virus from chimpanzees. The rarity of successful zoonosis is due to effective species barriers that are mediated partly by dominant antiviral factors, termed restriction factors. The tripartite motif protein TRIM5 alpha has emerged as an important restriction factor controlling species-specific retroviral replication. TRIM5 alpha was identified as an antiviral factor, active against HIV-1, in rhesus macaques. Subsequently, it was shown to encode previously described antiviral factors in humans (Ref 1) and monkeys (Lv1). TRIM5 alpha. causes a block to sensitive retroviral infection after viral entry into the target cell and usually before viral DNA synthesis. This review considers the role of TRIM5 alpha as an antiviral protein in mammals. Recent results from mutational analysis of TRIM5 alpha and their contribution to a mechanistic model for TRIM5 alpha antiviral activity are discussed, as is the future for postentry restriction factors.